Future Local Coverage Determination (LCD): myPath Melanoma Assay

New MolDX Policy:

CGS Administrators has a new MolDx policy that will take effect on June 3, 2019, MolDX: myPath Melanoma Assay L37907. This policy is currently in notice period and all comments received are in the response to comments article that is attached to the policy.

Source: https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=37907&ContrId=239&ver=3&ContrVer=1&CntrctrSelected=239%2A1&Cntrctr=239&DocType=4&bc=AAACAAQAAAAA&